• Home
  • NEW DAY MEDICINE
  • 8 (70) 2024
  • 57 -8 (70) 2024 - Gaybullaev A.A., Ermatov N.J. - DAILY CALCIUM LEVEL IN URINE DURING METAPHYLAXIS OF PATIENTS WITH CALCIUM OXALATE UROLITHIASIS

57 -8 (70) 2024 - Gaybullaev A.A., Ermatov N.J. - DAILY CALCIUM LEVEL IN URINE DURING METAPHYLAXIS OF PATIENTS WITH CALCIUM OXALATE UROLITHIASIS

DAILY CALCIUM LEVEL IN URINE DURING METAPHYLAXIS OF PATIENTS WITH CALCIUM OXALATE UROLITHIASIS

Gaybullaev A.A. - Center for the Development of Professional Qualifications of Medical Workers under the Ministry of Health of the Republic of Uzbekistan

Ermatov N.J. - Tashkent Medical Academy (TMA) Uzbekistan

Kuchkarov A.K. - Center for the Development of Professional Qualifications of Medical Workers under the Ministry of Health of the Republic of Uzbekistan

Resume

This article presents information on calcium excretion in daily urine in 154 patients over 18 years of age. All patients were examined at the 1st city clinical hospital named after Ibn Sina in Tashkent. All patients were diagnosed with calcium oxalate urolithiasis. The patients were prescribed diet therapy for the purpose of metaphylaxis of calcium oxalate urolithiasis, a month after the spontaneous passage of the stone or its surgical removal. Over the course of 65 days, the patients' calcium excretion in daily urine was measured over time.

Key words: Urinary stone disease, urolithiasis, calcium oxalate, metabolic syndrome, metaphylaxis.

First page

316

Last page

322

For citation:Gaybullaev A.A., Ermatov N.J., Kuchkarov A.K. - DAILY CALCIUM LEVEL IN URINE DURING METAPHYLAXIS OF PATIENTS WITH CALCIUM OXALATE UROLITHIASIS//New Day in Medicine 8(70)2024 316-322 https://newdayworldmedicine.com/en/new_day_medicine/8-70-2024

List of References

  1. Яненко Э.К., Меринов Д.С., Константинова О.В. Епишов В.А., Калиниченко Д.Н. Современные тенденции в эпидемиологии, диагностике и лечении мочекаменной болезни. //Экспериментальная и клиническая урология 2012;(3):19-24.
  2. Дутов В.В. Современные аспекты диагностики и лечения мочекаменной болезни у пациентов пожилого и старческого возраста. //Русский медицинский журнал 2014;(29):2100-2104.
  3. Niemann T, Kollmann T, Bongartz G. Diagnostic performance of low-dose CT for the detection of urolithiasis: a meta-analysis. //AJR Am J Roentgenol 2008;191(2):396-401.
  4. Beltrami P, Ruggera L, Guttilla A, Iannetti A, Zattoni F, Gigli F, et al. Te endourological treatment of renal matrix stones. //Urol Int 2014;93(4):394-8.
  5. Berkman DS, Landman J, Gupta M. Treatment outcomes after endopyelotomy performed with or without simultaneous nephrolithotomy: 10-year experience. //J Endourol 2009;23(9):1409-13.
  6. Каприн А.Д., Аполихин О.И., Сивков А.В., Москалева Н.Г., Солнцева Т.В., Комарова В.А. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за за 2003-2013 гг. //Экспериментальная и клиническая урология 2015;(2):4-12.
  7. Sánchez-Martin FM, Millán Rodriguez F, Esquena Fernández S, et al. Incidence and prevalence of published studies about urolithiasis in Spain. A review. //Actas Urol Esp 2007;31(5):511-20.
  8. Yasui T, Ando R, Okada A, Tozawa K, Iguchi M, Kohri K. Epidemiology of urolithiasis for improving clinical practic. //Hinyokika Kiyo 2012;58(12):697-701.
  9. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. //Kidney Int 2003;63(5):1817-1823.
  10. Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, et al. Guidelines on Urolithiasis. European Association of Urology 2015. Available from: http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR_full.pdf
  11. Колпаков И.С. Мочекаменная болезнь. /Пособие для врачей. М., 2006, 21 С.
  12. Глыбочко П.В., Аляев Ю.Г., Рапопорт Л.М., Цариченко Д.Г., Фролова Е.А. Cовременная консервативная (цитратная) терапия при уратных камнях мочеточников. //Урология 2014;(5):10-13.
  13. El-Gamal O, El-Bendary M, Ragab M, Rasheed M. Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi. //Urol Res 2012;40(3):219-24.
  14. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate--a criticalreview. //Urol Res 2005;33(2):73-79.
  15. Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. //Nephron Clin Pract. 2010;116(3):159-171.
  16. Ekeruo WO, Tan YH, Young MD. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. //J Urol. 2004;172:159-163.
  17. Тиктинский О.Л., Александров В.П. Мочекаменная болезнь. СПб.: Питер, 2000. 384c.
  18. Hussain M, Rizvi SA, Askari H, Sultan G, Lal M, Ali B, Naqvi SA. Management of stone disease: 17 years’ experience of a stone clinic in a developing country. //J Pak Med Assoc. 2009.
  19. Eisner BH, Goldfarb DS, Pareek G. Pharmacologic treatment of kidney stone disease. //Urol Clin North Am. 2013;40(1):21-30.
  20. Диагностика и неселективная терапия кальциевого уролитиаза. (методические рекомендации Ташкент 2018) Гайбуллаев А.А., Кариев С.С.

    file

    download